NASDAQ: CLRB - Cellectar Biosciences, Inc.

Rentabilité sur six mois: -85.67%
Rendement en dividendes: 0%
Secteur: Healthcare

Nouvelles

4 Medical Product Stocks to Buy From a Challenging Industry

17 avril 12:52 4 Medical Product Stocks to Buy From a Challenging Industry